Inactive Instrument

TOTL BRAI

Equities

TTB

AU0000032435

Total Brain Limited Has Enters A Perpetual, Non-Exclusive License with Janssen Research & Development, LLC

December 20, 2021 at 05:39 pm EST

Total Brain Limited has entered a perpetual, non-exclusive license with Janssen Research & Development, LLC for its iSPOT-D research data, effective immediately. Total Brain will receive a one-off license fee of USD $2.2M within 90 days. The license is subject to conventional commercial termination provisions.

Latest news about TOTL BRAI

Transcript : Total Brain Limited - Shareholder/Analyst Call	23-03-09
Total Brain Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-28	CI
Total Brain to Delist on Australian Bourse on March 1	23-02-14	MT
Transcript : Total Brain Limited - Shareholder/Analyst Call	23-01-31
David Daglio Steps Down from Board of Directors of Total Brain Limited	22-12-05	CI
Total Brain Completes Business Asset Sale to SonderMind; Shares Up 5%	22-10-31	MT
SonderMind Inc. acquired Assets of Total Brain Limited.	22-10-31	CI
Transcript : Total Brain Limited - Shareholder/Analyst Call	22-10-30
Total Brain Limited Auditor Raises 'Going Concern' Doubt	22-09-29	CI
Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-30	CI
Total Brain Agrees to Salell Business for $10 Million	22-08-05	MT
SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for $10 million.	22-08-04	CI
Total Brain Limited announced that it expects to receive AUD 0.0396 million in funding	22-06-01	CI
VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders	22-05-26	CI
Total Brain Limited Announces 5-Year Extension of AARP Contract	22-05-10	CI
Transcript : Total Brain Limited, Q3 2022 Earnings Call, May 04, 2022	22-05-03
Total Brain Limited announced that it expects to receive AUD 1.278485 million in funding	22-04-04	CI
Total Brain Limited Provides Varga Capital Loan Update	22-03-29	CI
Total Brain Limited Announces Repayment of F45 Loan	22-03-21	CI
Total Brain Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-27	CI
Transcript : Total Brain Limited, Q2 2022 Earnings Call, Feb 03, 2022	22-02-02
Kerna Health Signs Deal with Total Brain Limited to Integrate Total Brain Platform into Existing Behavioral Health Technologies	22-01-13	CI
Australian Shares Hit Nearly Four-Month High Despite Record COVID-19 Cases	21-12-29	MT
Total Brain Surges 18% Following Licensing Deal With Alto Neuroscience	21-12-28	MT
Total Brain Limited Enters into Data Licensing Deal with Alto Neuroscience	21-12-28	CI

Chart TOTL BRAI

Duration

Period

More charts

Company Profile

Total Brain Limited is an Australia-based company focused on developing and selling brain health products. It is engaged in the development and commercialization of brain health products, primarily delivered to a range of users through Total Brain platform. The Company's Total Brain platform is a neuroscience-based mental health and brain performance solution that starts with a self-monitoring and self-care app for individuals that drives robust team analytics for companies and ongoing monitoring for providers. The Company's Total Brain app allows individuals to self-monitor brain capacities, screen for mental health risks, and improve overall mental health and brain performance with self-care exercises to improve overall brain capacity and mental health. The Total Brain app functions include self-monitoring brain capacities and mental state; screen for risk of common mental conditions; personalized self-care recommendations for improved mental health, and in-the-moment stress relief.

Sector

More about the company